Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10877)
All Articles published online
|
Publishing Process of This Article
|
Mar 27, 2015 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kinoshita A, Onoda H, Fushiya N, Koike K, Nishino H, Tajiri H. Staging systems for hepatocellular carcinoma: Current status and future perspectives. World J Hepatol 2015; 7(3): 406-424 [PMID: 25848467 DOI: 10.4254/wjh.v7.i3.406] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i3/406.htm |
| Number | Citing Articles |
| 1 |
Nicole Huge, Maria Sandbothe, Anna K. Schröder, Amelie Stalke, Marlies Eilers, Vera Schäffer, Brigitte Schlegelberger, Thomas Illig, Beate Vajen, Britta Skawran. Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma. Hepatology International 2020; 14(3): 373 doi: 10.1007/s12072-019-09977-w
|
| 2 |
Darmadi Darmadi, Riska Habriel Ruslie, Cennikon Pakpahan. Association between serum midkine levels and tumor size in Indonesian hepatocellular carcinoma patients: a cross-sectional study. Romanian Journal of Internal Medicine 2022; 60(4): 229 doi: 10.2478/rjim-2022-0014
|
| 3 |
Jia-yan Ni, Jian Kong, Hong-liang Sun, Yao-ting Chen, Jiang-hong Luo, Wei-dong Wang, Dong Chen, Xiong-ying Jiang, Lin-feng Xu. Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas. Academic Radiology 2018; 25(4): 423 doi: 10.1016/j.acra.2017.10.018
|
| 4 |
M. Dobrzycka, P. Spychalski, O. Rostkowska, M. Wilczyński, P. Kobiela, M. Grąt, V. Dell’Acqua, M. Høyer, B. A. Jereczek-Fossa. Stereotactic body radiation therapy for early-stage hepatocellular carcinoma – a systematic review on outcome. Acta Oncologica 2019; 58(12): 1706 doi: 10.1080/0284186X.2019.1657942
|
| 5 |
Po-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, Yun-Hsuan Lee, Chien-Wei Su, Yi-Hsiang Huang, Fa-Yauh Lee, Han-Chieh Lin, Teh-Ia Huo. Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems. Journal of Hepatology 2016; 64(3): 601 doi: 10.1016/j.jhep.2015.10.029
|
| 6 |
Yin Lai, Jin‐Chiao Lee, Hao‐Chien Hung, Chih‐Hsien Cheng, Tsung‐Han Wu, Chen‐Fang Lee, Ting‐Jung Wu, Hong‐Shiue Chou, Kun‐Ming Chan, Wei‐Chen Lee. Models to predict disease‐free survival for hepatocellular carcinoma patients with surgical resections. Journal of Surgical Oncology 2020; 122(7): 1444 doi: 10.1002/jso.26169
|
| 7 |
Etimad Huwait, Seham M. Awaji, Taha A. Kumosani, Elie K. Barbour, Khalid O. Abulnaja, Said S. Moselhy. Ruthana date extract inhibited proliferation of human hepatocellular carcinoma (HepG2) cells by modulation of BAX gene. Environmental Science and Pollution Research 2022; 29(42): 63369 doi: 10.1007/s11356-022-20240-y
|
| 8 |
Rim Messaoudi, Faouzi Jaziri, Achraf Mtibaa, Manuel Grand-Brochier, Hawa Mohamed Ali, Ali Amouri, Hela Fourati, Pascal Chabrot, Faiez Gargouri, Antoine Vacavant. Ontology-Based Approach for Liver Cancer Diagnosis and Treatment. Journal of Digital Imaging 2019; 32(1): 116 doi: 10.1007/s10278-018-0115-6
|
| 9 |
Ihab Barsoum, Marwan N. Elgohary, Mohamed A.A. Bassiony. Lipocalin-2: A novel diagnostic marker for hepatocellular carcinoma. Cancer Biomarkers 2020; 28(4): 523 doi: 10.3233/CBM-190084
|
| 10 |
Stephen P Hack, Jessica Spahn, Minshan Chen, Ann-Lii Cheng, Ahmed Kaseb, Masatoshi Kudo, Han Chu Lee, Adam Yopp, Pierce Chow, Shukui Qin. IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation. Future Oncology 2020; 16(15): 975 doi: 10.2217/fon-2020-0162
|
| 11 |
|
| 12 |
Tin Nadarevic, Agostino Colli, Vanja Giljaca, Mirella Fraquelli, Giovanni Casazza, Cristina Manzotti, Davor Štimac, Damir Miletic. Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database of Systematic Reviews 2021; doi: 10.1002/14651858.CD014798
|
| 13 |
Yitian Qi, Yi Hou, Liangchen Qi. miR-30d-5p represses the proliferation, migration, and invasion of lung squamous cell carcinoma via targeting DBF4. Journal of Environmental Science and Health, Part C 2021; : 1 doi: 10.1080/26896583.2021.1926855
|
| 14 |
Chengkai Yang, Huaxiang Wang, Jianyong Liu, Fang Yang, Lizhi Lv, Yi Jiang, Qiucheng Cai. Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1134933
|
| 15 |
Tomoaki Yoh, Satoru Seo, Satoshi Ogiso, Takayuki Kawai, Yukihiro Okuda, Takamichi Ishii, Kojiro Taura, Tatsuya Higashi, Yuji Nakamoto, Etsuro Hatano, Toshimi Kaido, Shinji Uemoto. Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma Incorporating 18F-FDG-PET Imaging with the ALBI Grade. Annals of Surgical Oncology 2018; 25(2): 542 doi: 10.1245/s10434-017-6262-z
|
| 16 |
Qinlu Zhao, Xin Yuan, Lian Zheng, Miaomiao Xue. miR-30d-5p: A Non-Coding RNA With Potential Diagnostic, Prognostic and Therapeutic Applications. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.829435
|
| 17 |
Tsung-Hsing Hung, Chih-Chun Tsai, Hsing-Feng Lee. The role of hepatic reserve in the mortality of cirrhotic patients with small hepatocellular carcinoma receiving radiofrequency ablation. Medicine 2022; 101(40): e30918 doi: 10.1097/MD.0000000000030918
|
| 18 |
Jia-yan Ni, Lin-feng Xu, Wei-dong Wang, Qiao-sheng Huang, Hong-liang Sun, Yao-ting Chen. Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1α for hepatocellular carcinoma: a preliminary study of rat model. Journal of Cancer Research and Clinical Oncology 2017; 143(2): 199 doi: 10.1007/s00432-016-2237-x
|
| 19 |
Adela Turcanu, Ecaterina Pitel, Vlada-Tatiana Dumbrava, Eugen Tcaciuc, Ana Donscaia, Angela Peltec, Pascal Pineau. Profile of hepatocellular carcinoma in the Republic of Moldova: first-hand information on the presentation, distribution and etiologies. Romanian Journal of Internal Medicine 2019; 57(1): 37 doi: 10.2478/rjim-2018-0026
|
| 20 |
Tin Nadarevic, Vanja Giljaca, Agostino Colli, Mirella Fraquelli, Giovanni Casazza, Damir Miletic, Davor Štimac. Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database of Systematic Reviews 2021; 2021(10) doi: 10.1002/14651858.CD013362.pub2
|
| 21 |
Takeshi Takamoto, Yasuhiko Sugawara, Takuya Hashimoto, Masatoshi Makuuchi. Evaluating the current surgical strategies for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2016; 10(3): 341 doi: 10.1586/17474124.2016.1116381
|
| 22 |
Agostino Colli, Tin Nadarević, Damir Miletić, Vanja Giljaca, Mirella Fraquelli, Davor Štimac, Giovanni Casazza. Abdominal ultrasound and alpha-fetoprotein for the diagnosis of hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2019; doi: 10.1002/14651858.CD013346
|
| 23 |
Ishith Seth, Adrian Siu, Lyndel Hewitt, Ulvi Budak, Beshoy Farah, Mouhannad Jaber. Clinical Practice Guidelines For the Management of Hepatocellular Carcinoma: A Systematic Review. Journal of Gastrointestinal Cancer 2023; doi: 10.1007/s12029-023-00961-0
|
| 24 |
Andrea Ruzzenente, Fabio Bagante, Francesca Ratti, Laura Alaimo, Hugo P. Marques, Silvia Silva, Olivier Soubrane, Itaru Endo, Kota Sahara, Eliza W. Beal, Vincent Lam, George A. Poultsides, Eleftherios A. Makris, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Thomas J. Hugh, Alfredo Guglielmi, Luca Aldrighetti, Timothy M. Pawlik. Minimally Invasive Versus Open Liver Resection for Hepatocellular Carcinoma in the Setting of Portal Vein Hypertension: Results of an International Multi-institutional Analysis. Annals of Surgical Oncology 2020; 27(9): 3360 doi: 10.1245/s10434-020-08444-3
|
| 25 |
Tin Nadarevic, Vanja Giljaca, Agostino Colli, Mirella Fraquelli, Giovanni Casazza, Damir Miletic, Davor Štimac. Computed tomography for the diagnosis of hepatocellular carcinoma in chronic advanced liver disease. Cochrane Database of Systematic Reviews 2019; doi: 10.1002/14651858.CD013362
|
| 26 |
Luca Boldrini, Angela Romano, Silvia Mariani, Davide Cusumano, Francesco Catucci, Lorenzo Placidi, Gian Carlo Mattiucci, Giuditta Chiloiro, Francesco Cellini, Maria Antonietta Gambacorta, Luca Indovina, Vincenzo Valentini. MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach. Journal of Cancer Research and Clinical Oncology 2021; 147(7): 2057 doi: 10.1007/s00432-020-03480-8
|
| 27 |
Xiaoyan Liao, Dongwei Zhang. The 8th Edition American Joint Committee on Cancer Staging for Hepato-pancreato-biliary Cancer: A Review and Update. Archives of Pathology & Laboratory Medicine 2021; 145(5): 543 doi: 10.5858/arpa.2020-0032-RA
|
| 28 |
R. K. Tannus, S. R. Almeida-Carvalho, C. A. Loureiro-Matos, A. Miziara-Gonzalez, A. A. Salzedas-Netto, D. Szejnfeld, G. D'Ippolito, V. Pereira-Lanzoni, I. Souza-Silva, Ferruccio Bonino. Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems. PLOS ONE 2018; 13(4): e0194922 doi: 10.1371/journal.pone.0194922
|
| 29 |
Konstantinos Damiris, Hamza Abbad, Nikolaos Pyrsopoulos. Cellular based treatment modalities for unresectable hepatocellular carcinoma. World Journal of Clinical Oncology 2021; 12(5): 290-308 doi: 10.5306/wjco.v12.i5.290
|
| 30 |
Santhasiri Orrapin, Sasimol Udomruk, Worakitti Lapisatepun, Sutpirat Moonmuang, Areerak Phanphaisarn, Phichayut Phinyo, Dumnoensun Pruksakorn, Parunya Chaiyawat. Clinical Implication of Circulating Tumor Cells Expressing Epithelial Mesenchymal Transition (EMT) and Cancer Stem Cell (CSC) Markers and Their Perspective in HCC: A Systematic Review. Cancers 2022; 14(14): 3373 doi: 10.3390/cancers14143373
|
| 31 |
Susanne Feder, Arne Kandulski, Doris Schacherer, Thomas S. Weiss, Christa Buechler. Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular Carcinoma. International Journal of Molecular Sciences 2019; 20(16): 3919 doi: 10.3390/ijms20163919
|
| 32 |
Patrick Vande Lune, Ahmed K. Abdel Aal, Sergio Klimkowski, Jessica G. Zarzour, Andrew J. Gunn. Hepatocellular Carcinoma: Diagnosis, Treatment Algorithms, and Imaging Appearance after Transarterial Chemoembolization. Journal of Clinical and Translational Hepatology 2017; 6(2): 1 doi: 10.14218/JCTH.2017.00045
|
| 33 |
Brian I. Carr, Vito Guerra. Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis. Digestive Diseases and Sciences 2016; 61(3): 937 doi: 10.1007/s10620-015-3922-3
|
| 34 |
Jella-Andrea Abraham, Olga Golubnitschaja. Time for paradigm change in management of hepatocellular carcinoma: is a personalized approach on the horizon?. Personalized Medicine 2016; 13(5): 455 doi: 10.2217/pme-2016-0013
|
| 35 |
Mihir D Shanker, Howard Y Liu, Yoo Young Lee, Katherine A Stuart, Elizabeth E Powell, Alan Wigg, David I Pryor. Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium. Journal of Gastroenterology and Hepatology 2021; 36(4): 873 doi: 10.1111/jgh.15175
|
| 36 |
Yulong Chen, Xunjun Yang, Yao Chen, Guorong Chen, Cheryl A. Winkler, Ping An, Jianxin Lyu. Impacts of the SOAT1 genetic variants and protein expression on HBV-related hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08245-1
|
| 37 |
Siddharth A. Padia, Robert J. Lewandowski, Guy E. Johnson, Daniel Y. Sze, Thomas J. Ward, Ron C. Gaba, Mark O. Baerlocher, Vanessa L. Gates, Ahsun Riaz, Daniel B. Brown, Nasir H. Siddiqi, T. Gregory Walker, James E. Silberzweig, Jason W. Mitchell, Boris Nikolic, Riad Salem. Radioembolization of Hepatic Malignancies: Background, Quality Improvement Guidelines, and Future Directions. Journal of Vascular and Interventional Radiology 2017; 28(1): 1 doi: 10.1016/j.jvir.2016.09.024
|
| 38 |
Amol Gupta, Jane Zorzi, Won Jin Ho, Marina Baretti, Nilofer Saba Azad, Paige Griffith, Doan Dao, Amy Kim, Benjamin Philosophe, Christos Georgiades, Ihab Kamel, Richard Burkhart, Robert Liddell, Kelvin Hong, Christopher Shubert, Kelly Lafaro, Jeffrey Meyer, Robert Anders, William Burns, Mark Yarchoan. Relationship of Hepatocellular Carcinoma Stage and Hepatic Function to Health-Related Quality of Life: A Single Center Analysis. Healthcare 2023; 11(18): 2571 doi: 10.3390/healthcare11182571
|
| 39 |
G A Siregar, R H Siregar. Gamma-glutamyltranspeptidase to platelet ratio and albumin to gamma-glutamyltranspeptidase between degrees of the Barcelona clinic liver cancer on hepatocellular carcinoma patients in Haji Adam Malik general hospital Medan during 2015-2016. IOP Conference Series: Earth and Environmental Science 2018; 125: 012135 doi: 10.1088/1755-1315/125/1/012135
|
| 40 |
Yue Xu, Xiaoqin Yao, Jinmei Li, Guoyuan Zhang, Guangcheng Luo, Qiang Wang. Establishment and application of a survival rate graph model based on biomarkers and imaging indexes after primary hepatocellular carcinoma resection. Cancer Medicine 2023; 12(12): 13329 doi: 10.1002/cam4.6031
|
| 41 |
Ming-Wei Lai, Yu-De Chu, Chih-Lang Lin, Rong-Nan Chien, Ta-Sen Yeh, Tai-Long Pan, Po-Yuan Ke, Kwang-Hui Lin, Chau-Ting Yeh. Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5453-3
|
| 42 |
Chenchu Xu, Dong Zhang, Jaron Chong, Bo Chen, Shuo Li. Synthesis of gadolinium-enhanced liver tumors on nonenhanced liver MR images using pixel-level graph reinforcement learning. Medical Image Analysis 2021; 69: 101976 doi: 10.1016/j.media.2021.101976
|
| 43 |
Jingli Ding, Zhili Wen. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08904-3
|
| 44 |
Daisuke Ban, Toshiro Ogura, Keiichi Akahoshi, Minoru Tanabe. Current topics in the surgical treatments for hepatocellular carcinoma. Annals of Gastroenterological Surgery 2018; 2(2): 137 doi: 10.1002/ags3.12065
|
| 45 |
Lindsay B. Young, Parissa Tabrizian, Jeffrey Sung, Derek Biederman, Vivian L. Bishay, Mona Ranade, Rahul S. Patel, Francis S. Nowakowski, Aaron M. Fischman, Robert A. Lookstein, Edward Kim. Survival Analysis Using Albumin-Bilirubin (ALBI) Grade for Patients Treated with Drug-Eluting Embolic Transarterial Chemoembolization for Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2022; 33(5): 510 doi: 10.1016/j.jvir.2022.02.005
|
| 46 |
Yanyan Long, Yan Liang, Shujie Li, Jing Guo, Ying Wang, Yan Luo, Yongzhong Wu. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies. Radiation Oncology 2021; 16(1) doi: 10.1186/s13014-021-01761-1
|
| 47 |
In-Gyu Kim, Xu-Guang Hu, Hee-Jung Wang, Bong-Wan Kim, Sung Yeon Hong, Xue-Yin Shen. The 7th/8th American Joint Committee on Cancer and the Modified Union for International Cancer Control Staging System for Hepatocellular Carcinoma. Yonsei Medical Journal 2019; 60(2): 140 doi: 10.3349/ymj.2019.60.2.140
|
| 48 |
Lulu Liu, Junwei Liu, Pan Li, Jijun Luo, Rui Qin, Qiao Peng, Bin Li, Xuyong Wei, Tian Wang, Hongyu Shi, Ming-Da Wang, Chao Li, Weijia Fang, Wei Chen, Xiao Xu, Tian Yang, Weiwei Yin, Xun Zeng. Single-cell analysis reveals HBV-specific PD-1+CD8+ TRM cells in tumor borders are associated with HBV-related hepatic damage and fibrosis in HCC patients. Journal of Experimental & Clinical Cancer Research 2023; 42(1) doi: 10.1186/s13046-023-02710-4
|
| 49 |
Jennifer N. Harmon, Foad Kabinejadian, Joseph L. Bull. Combined gas embolization and chemotherapy can result in complete tumor regression in a murine hepatocellular carcinoma model. APL Bioengineering 2020; 4(3) doi: 10.1063/5.0005329
|
| 50 |
|
| 51 |
Dongwei Zhang, Tanzy Love, Yansheng Hao, Bella Lingjia Liu, Swan Thung, Maria Isabel Fiel, Christa L Whitney-Miller, Xiaoyan Liao. Tumor Size, Not Small Vessel Invasion, Predicts Survival in Patients With Hepatocellular Carcinoma. American Journal of Clinical Pathology 2022; 158(1): 70 doi: 10.1093/ajcp/aqac001
|
| 52 |
Min Wu, Qi-man Shi, Sai-Li Duan, Deng-jie Ou-yang, Pei Chen, Biao Tu, Peng Huang. Insights into the Association Between QSER1 and M2 Macrophages and Remarkable Malignancy Characteristics in Hepatocellular Carcinoma. International Journal of General Medicine 2022; : 1765 doi: 10.2147/IJGM.S352574
|
| 53 |
Darmadi Darmadi, Riska Habriel Ruslie, Cennikon Pakpahan. Vascular Endothelial Growth Factor Levels Difference among Hepatocellular Cancer Patients Based on Barcelona Clinic Liver Cancer Staging. Open Access Macedonian Journal of Medical Sciences 2021; 9(B): 797 doi: 10.3889/oamjms.2021.6598
|
| 54 |
Chun-Ting Fan, Wei-Wen Lin, Ming-Jer Chen, Sz-Iuan Shiu. Isolated Right Ventricular Metastasis in a Woman with Advanced Hepatocellular Carcinoma after Palliative Therapy. Case Reports in Gastroenterology 2019; 13(3): 487 doi: 10.1159/000504566
|
| 55 |
Yang Hai, Esika Savsani, Weelic Chong, John Eisenbrey, Andrej Lyshchik. Meta-analysis and systematic review of contrast-enhanced ultrasound in evaluating the treatment response after locoregional therapy of hepatocellular carcinoma. Abdominal Radiology 2021; 46(11): 5162 doi: 10.1007/s00261-021-03248-9
|
| 56 |
Tao Yan, Chenyang Huang, Jin Lei, Qian Guo, Guodong Su, Tong Wu, Xueyuan Jin, Caiyun Peng, Jiamin Cheng, Linzhi Zhang, Zherui Liu, Terence Kin, Fan Ying, Suthat Liangpunsakul, Yinyin Li, Yinying Lu. Development and Validation of a nomogram for forecasting survival of alcohol related hepatocellular carcinoma patients. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.976445
|
| 57 |
Rajangad S. Gurtatta, Sydney E. Whalen, Charles E. Ray. Biologics, Immunotherapies, and Cytotoxic Chemotherapy for Hepatocellular Carcinoma following Current Recommendations by the BCLC: A Review of Agents. Seminars in Interventional Radiology 2024; 41(01): 084 doi: 10.1055/s-0043-1778660
|
| 58 |
Alexander W. Coombs, Chloe Jordan, Sabba A. Hussain, Omar Ghandour. Scoring systems for the management of oncological hepato-pancreato-biliary patients. Annals of Hepato-Biliary-Pancreatic Surgery 2022; 26(1): 17 doi: 10.14701/ahbps.21-113
|
| 59 |
Chern-Horng Lee, Sen-Yung Hsieh, Chih-Chun Chang, I-Kuan Wang, Wen-Hung Huang, Cheng-Hao Weng, Ching-Wei Hsu, Tzung-Hai Yen. Hepatocellular carcinoma in hemodialysis patients. Oncotarget 2017; 8(42): 73154 doi: 10.18632/oncotarget.17127
|
| 60 |
Rie Matsushima-Nishiwaki, Hidenori Toyoda, Tomoaki Nagasawa, Eisuke Yasuda, Naokazu Chiba, Seiji Okuda, Atsuyuki Maeda, Yuji Kaneoka, Takashi Kumada, Osamu Kozawa, Xin-Yuan Guan. Phosphorylated Heat Shock Protein 20 (HSPB6) Regulates Transforming Growth Factor-α-Induced Migration and Invasion of Hepatocellular Carcinoma Cells. PLOS ONE 2016; 11(4): e0151907 doi: 10.1371/journal.pone.0151907
|
| 61 |
Zhengwei Li, Ying Wang. miR-96 targets SOX6 and promotes proliferation, migration, and invasion of hepatocellular carcinoma. Biochemistry and Cell Biology 2018; 96(3): 365 doi: 10.1139/bcb-2017-0183
|
| 62 |
Jelena Djokić Kovač, Milica Mitrović, Aleksandra Janković, Marko Andrejević, Aleksandar Bogdanović, Predrag Zdujić, Uroš Đinđić, Vladimir Dugalić. Hepatocellular Carcinoma Presenting Simultaneously with Echinococcal Cyst Mimicking a Single Liver Lesion in a Non-Cirrhotic Patient: A Case Report and Review of the Literature. Diagnostics 2022; 12(7): 1583 doi: 10.3390/diagnostics12071583
|
| 63 |
Damien Bouda, Matthieu Lagadec, Carmela Garcia Alba, Vincent Barrau, Marco Dioguardi Burgio, Nadia Moussa, Valérie Vilgrain, Maxime Ronot. Imaging review of hepatocellular carcinoma after thermal ablation: The good, the bad, and the ugly. Journal of Magnetic Resonance Imaging 2016; 44(5): 1070 doi: 10.1002/jmri.25369
|
| 64 |
Hien Dang, Yotsawat Pomyen, Sean P. Martin, Dana A. Dominguez, Sun Young Yim, Ju-Seog Lee, Anuradha Budhu, Ashesh P. Shah, Adam S. Bodzin, Xin Wei Wang. NELFE-Dependent MYC Signature Identifies a Unique Cancer Subtype in Hepatocellular Carcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-39727-9
|
| 65 |
Yuexiang Niu, Gongen Tang. miR‑185‑5p targets ROCK2 and inhibits cell migration and invasion of hepatocellular carcinoma. Oncology Letters 2019; doi: 10.3892/ol.2019.10144
|
| 66 |
Dillip Kumar Bishi, Priyadarshini Padhi, Chhabi Rani Panigrahi, Bibudhendu Pati, Chandi Charan Rath. Computational Intelligence in Cancer Diagnosis. 2023; : 317 doi: 10.1016/B978-0-323-85240-1.00013-4
|
| 67 |
Li-Yun Tsai, Yu-Wei Chang, Ming-Che Lee, Ying-Chen Chang, Pei-Ing Hwang, Yi-Shuian Huang, Ching-Feng Cheng, Olorunseun Ogunwobi. Biphasic and Stage-Associated Expression of CPEB4 in Hepatocellular Carcinoma. PLOS ONE 2016; 11(5): e0155025 doi: 10.1371/journal.pone.0155025
|
| 68 |
Tin Nadarevic, Agostino Colli, Vanja Giljaca, Mirella Fraquelli, Giovanni Casazza, Cristina Manzotti, Davor Štimac, Damir Miletic. Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database of Systematic Reviews 2022; 2022(5) doi: 10.1002/14651858.CD014798.pub2
|
| 69 |
Michele Campigotto, Mauro Giuffrè, Anna Colombo, Alessia Visintin, Alessandro Aversano, Martina Budel, Flora Masutti, Cristiana Abazia, Lory Saveria Crocé. Comparison between hepatocellular carcinoma prognostic scores: A 10-year single-center experience and brief review of the current literature. World Journal of Hepatology 2020; 12(12): 1239-1257 doi: 10.4254/wjh.v12.i12.1239
|
| 70 |
Ashraf Omar, Ahmed Kaseb, Tamer Elbaz, Mohamed El-Kassas, Amr El Fouly, Abdel Fatah Hanno, Ahmed El Dorry, Ahmed Hosni, Amr Helmy, Amr S Saad, Ashwaq Alolayan, Basem Eysa, Emad Hamada, Hamdy Azim, Hany Khattab, Hesham Elghazaly, Hesham Tawfik, Hisham Ayoub, Hussein Khaled, Ibtessam Saadeldin, Imam Waked, Eman Barakat, Mahmoud El Meteini, Mohamed Hamed Shaaban, Mohamed EzzElarab, Mohamed Fathy, Mohamed Shaker, Mohamed Sobhi, Mohamed Shaker, Mohamed ElGharib, Mohammed Abdullah, Mohesn Mokhtar, Mostafa Elshazli, Omar Heikal, Osama Hetta, Reda ElWakil, Sameh Abdel Wahab, Samir Eid, Yousri Rostom. Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 1547 doi: 10.2147/JHC.S404424
|
| 71 |
Shuai He, Jin-Feng Li, Hao Tian, Ye Sang, Xiao-Jing Yang, Gui-Xin Guo, Jin-E Yang. A long non-coding RNA-based signature predicts early recurrence in hepatocellular carcinoma. Cancer Biomarkers 2022; 34(2): 309 doi: 10.3233/CBM-210193
|
| 72 |
Yukio Tokumitsu, Hiroaki Nagano. Hepatocellular Carcinoma. 2016; : 425 doi: 10.1007/978-3-319-34214-6_28
|
| 73 |
Mirella Fraquelli, Tin Nadarevic, Agostino Colli, Cristina Manzotti, Vanja Giljaca, Damir Miletic, Davor Štimac, Giovanni Casazza. Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database of Systematic Reviews 2022; 2022(9) doi: 10.1002/14651858.CD013483.pub2
|
| 74 |
Abdallah H. Fathy, Mohamed A. Bashandy, Samir A.E. Bashandy, Ahmed M. Mansour, Bakheet Elsadek. Sequential analysis and staging of a diethylnitrosamine-induced hepatocellular carcinoma in male Wistar albino rat model. Canadian Journal of Physiology and Pharmacology 2017; 95(12): 1462 doi: 10.1139/cjpp-2017-0413
|
| 75 |
Jordan D. LeGout, Ryan E. Bailey, Candice W. Bolan, Andrew W. Bowman, Frank Chen, Joseph G. Cernigliaro, Lauren F. Alexander. Multimodality Imaging of Abdominopelvic Tumors with Venous Invasion. RadioGraphics 2020; 40(7): 2098 doi: 10.1148/rg.2020200047
|
| 76 |
Murtuza Razi, Gu Jianping, He Xu, Mohammed Jameeluddin Ahmed. Conventional versus drug-eluting bead transarterial chemoembolization: A better option for treatment of unresectable hepatocellular carcinoma. Journal of Interventional Medicine 2021; 4(1): 11 doi: 10.1016/j.jimed.2020.10.006
|
| 77 |
Xinjie Hao, Ruopei Xin, Wenjing Dong. Decreased serum exosomal miR-320a expression is an unfavorable prognostic factor in patients with hepatocellular carcinoma. Journal of International Medical Research 2020; 48(4): 030006051989614 doi: 10.1177/0300060519896144
|
| 78 |
Man Tong, Tin-Lok Wong, Hongzhi Zhao, Yuanyuan Zheng, Yu-Nong Xie, Cheuk-Hin Li, Lei Zhou, Noélia Che, Jing-Ping Yun, Kwan Man, Terence Kin-Wah Lee, Zongwei Cai, Stephanie Ma. Loss of tyrosine catabolic enzyme HPD promotes glutamine anaplerosis through mTOR signaling in liver cancer. Cell Reports 2021; 36(8): 109617 doi: 10.1016/j.celrep.2021.109617
|
| 79 |
Giulia Morsica, Laura Galli, Emanuela Messina, Alessandro Cibarelli, Sabrina Bagaglio, Andrea Poli, Martina Ranzenigo, Antonella Castagna, Hamid Hasson, Caterina Uberti-Foppa, Alessandro Granito. Levels of Alpha-Fetoprotein and Association with Mortality in Hepatocellular Carcinoma of HIV-1-Infected Patients. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/3586064
|
| 80 |
Thi Ngoc Anh Nguyen, Po-Shuan Huang, Po-Yu Chu, Chia-Hsun Hsieh, Min-Hsien Wu. Recent Progress in Enhanced Cancer Diagnosis, Prognosis, and Monitoring Using a Combined Analysis of the Number of Circulating Tumor Cells (CTCs) and Other Clinical Parameters. Cancers 2023; 15(22): 5372 doi: 10.3390/cancers15225372
|
| 81 |
Qiang Cai, Shizhe Yu, Jian Zhao, Duo Ma, Long Jiang, Xinyi Zhang, Zhiyong Yu, Ashok Pandurangan. The Landscape of Using Glycosyltransferase Gene Signatures for Overall Survival Prediction in Hepatocellular Carcinoma. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/5989419
|
| 82 |
Duk-Ju Kim, In Chul-Nam, Sung-Eun Park, Doo-Ri Kim, Jeong-Sub Lee, Bong-Soo Kim, Guk-Myung Choi, JeongJae Kim, Jung-Ho Won. Added Value of Cone-Beam Computed Tomography for Detecting Hepatocellular Carcinomas and Feeding Arteries during Transcatheter Arterial Chemoembolization Focusing on Radiation Exposure. Medicina 2023; 59(6): 1121 doi: 10.3390/medicina59061121
|
| 83 |
Carolin Czauderna, Irene Schmidtmann, Sandra Koch, Lukas Pilz, Sophia Heinrich, Gerd Otto, Jens Mittler, Hauke Lang, Roman Kloeckner, Christoph Düber, Martin F. Sprinzl, Marcus A. Worns, Peter R. Galle, Jens U. Marquardt, Arndt Weinmann. High pretreatment static and dynamic alpha‐fetoprotein values predict reduced overall survival in hepatocellular carcinoma. United European Gastroenterology Journal 2021; 9(3): 388 doi: 10.1177/2050640620972611
|
| 84 |
Luca Bertero, Federica Massa, Jasna Metovic, Roberto Zanetti, Isabella Castellano, Umberto Ricardi, Mauro Papotti, Paola Cassoni. Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria—What has changed and why?. Virchows Archiv 2018; 472(4): 519 doi: 10.1007/s00428-017-2276-y
|
| 85 |
Shangyi Luo, Ying Jia, Yajing Zhang, Xue Zhang. WITHDRAWN: A transcriptomic intratumor heterogeneity-free signature overcomes sampling bias in prognostic risk classification for hepatocellular carcinoma. JHEP Reports 2023; : 100748 doi: 10.1016/j.jhepr.2023.100748
|
| 86 |
Mirella Fraquelli, Tin Nadarevic, Vanja Giljaca, Agostino Colli, Damir Miletic, Davor Štimac, Giovanni Casazza. Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in advanced chronic liver disease. Cochrane Database of Systematic Reviews 2019; doi: 10.1002/14651858.CD013483
|
| 87 |
Yunhong Tian, Tie Li, Shouliang Qi, Hani Alhourani, Binyu Luo, Junjie Chenqin, Qizhong Fu, Yong Peng, Jianlin Wu. The impact of metabolic syndrome (MetS) on surgical outcome for patients with mostly HBV‐related hepatocellular carcinoma (HCC) underwent hepatectomy. Journal of Surgical Oncology 2020; 122(4): 699 doi: 10.1002/jso.26055
|
| 88 |
Liwen Guo, Jiaping Zheng, Jun Luo, Zhewei Zhang, Guoliang Shao. <p>Targeting Yes1 Associated Transcriptional Regulator Inhibits Hepatocellular Carcinoma Progression and Improves Sensitivity to Sorafenib: An in vitro and in vivo Study</p>. OncoTargets and Therapy 2020; : 11071 doi: 10.2147/OTT.S249412
|
| 89 |
Diwakar Suresh, Akshatha N. Srinivas, Akila Prashant, Kuzhuvelil B. Harikumar, Divya P. Kumar. Therapeutic options in hepatocellular carcinoma: a comprehensive review. Clinical and Experimental Medicine 2023; 23(6): 1901 doi: 10.1007/s10238-023-01014-3
|
| 90 |
Fengping Jiao, Lu Long, Shanlong Ding, Xiaomeng Xie, Le Jia, Fengmin Lu. Complete genome sequencing and clinical analysis of intrahepatic hepatitis B virus cccDNA from HCC. Microbial Pathogenesis 2017; 109: 49 doi: 10.1016/j.micpath.2017.04.028
|
| 91 |
Bohyun Kim, Soon Sun Kim, Sung Won Cho, Jae Youn Cheong, Jimi Huh, Jai Keun Kim, Jei Hee Lee, Hye Ri Ahn, Hyo Jung Cho. Liver stiffness in magnetic resonance elastography is prognostic for sorafenib-treated advanced hepatocellular carcinoma. European Radiology 2021; 31(4): 2507 doi: 10.1007/s00330-020-07357-9
|
| 92 |
Zhenhua Du, Xinyi Liu, Xiaojun Wei, Hongbo Luo, Peiyao Li, Mengting Shi, Bingqian Guo, Ying Cui, Zhenglin Su, Jifeng Zeng, Anfeng Si, Pengbo Cao, Gangqiao Zhou. Quantitative proteomics identifies a plasma multi-protein model for detection of hepatocellular carcinoma. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-72510-9
|
| 93 |
Wei Sang, Stephen L. Chan, Anthony W.H. Chan. Comments on “Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patients”. European Journal of Cancer 2016; 68: 203 doi: 10.1016/j.ejca.2016.08.023
|
| 94 |
Chengyong Liu, Chunying Wang, Ji Wang, Haibin Huang. miR-1297 promotes cell proliferation by inhibiting RB1 in liver cancer. Oncology Letters 2016; 12(6): 5177 doi: 10.3892/ol.2016.5326
|
| 95 |
Jiali Chen, Kun He, Yunwei Han, Lu Guo, Ke Su, Zhenying Wu. Clinical efficacy and safety of external radiotherapy combined with sorafenib in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Annals of Hepatology 2022; 27(4): 100710 doi: 10.1016/j.aohep.2022.100710
|
| 96 |
Shraddha Patkar, Amir Parray, Balu Mahendra, Sagar Kurunkar, Mahesh Goel. Performance of Hong Kong Liver Cancer staging system in patients of hepatocellular carcinoma treated with surgical resection: An Indian validation study. Journal of Surgical Oncology 2019; 120(7): 1119 doi: 10.1002/jso.25704
|
| 97 |
Shangyi Luo, Ying Jia, Yajing Zhang, Xue Zhang. A transcriptomic intratumour heterogeneity-free signature overcomes sampling bias in prognostic risk classification for hepatocellular carcinoma. JHEP Reports 2023; 5(6): 100754 doi: 10.1016/j.jhepr.2023.100754
|
| 98 |
Yoon Jung Hwang, Jae Seok Bae, Youngeun Lee, Bo Yun Hur, Dong Ho Lee, Haeryoung Kim. Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging. Clinical and Molecular Hepatology 2023; 29(3): 733 doi: 10.3350/cmh.2023.0034
|
| 99 |
Agostino Colli, Tin Nadarevic, Damir Miletic, Vanja Giljaca, Mirella Fraquelli, Davor Štimac, Giovanni Casazza. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database of Systematic Reviews 2021; 2021(4) doi: 10.1002/14651858.CD013346.pub2
|
| 100 |
Joshua P. Kronenfeld, Emily L. Ryon, David Goldberg, Rachel M. Lee, Adam Yopp, Annie Wang, Ann Y. Lee, Sommer Luu, Cary Hsu, Eric Silberfein, Maria C. Russell, Nipun B. Merchant, Neha Goel. Survival inequity in vulnerable populations with early-stage hepatocellular carcinoma: a United States safety-net collaborative analysis. HPB 2021; 23(6): 868 doi: 10.1016/j.hpb.2020.11.1150
|
| 101 |
Marie Dupuy, Sarah Iltache, Benjamin Rivière, Alexandre Prieur, George Philippe Pageaux, José Ursic Bedoya, Stéphanie Faure, Heloïse Guillaumée, Eric Assenat. Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for Hepatocellular Carcinoma. Cancers 2022; 14(2): 402 doi: 10.3390/cancers14020402
|
| 102 |
Francesco Cammarata, Laura Benuzzi, Michele Crespi, Albert Troci, Luca Pennacchi, Monica Schiavini, Diego Foschi. Liver resection of hepatocellular carcinoma in HIV-HCV co-infected patients: a retrospective case series. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00215-x
|